These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6947406)

  • 1. Azlocillin treatment of urinary tract infection in patients on haemodialysis.
    Hallan H; Svarva PL; Svartås TM; Widerøe T
    Scand J Infect Dis Suppl; 1981; 29():55-8. PubMed ID: 6947406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with azlocillin in complicated urinary tract infections.
    Alfthan O; Renkonen OV; Ohlsson H
    Arzneimittelforschung; 1979; 29(12a):1979-81. PubMed ID: 543906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative treatment with azlocillin in complicated urinary tract infections.
    Alfthan O; Renkonen OV; Ohlsson H
    Scand J Infect Dis Suppl; 1981; 29():98-101. PubMed ID: 6947409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azlocillin kinetics during extracorporeal haemodialysis and peritoneal dialysis.
    Whelton A; Stout RL; Delgado FA
    J Antimicrob Chemother; 1983 May; 11 Suppl B():89-95. PubMed ID: 6619036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics after discontinuous intravenous administration of azlocillin].
    Naber K; Adam D
    Arzneimittelforschung; 1983; 33(3):429-32. PubMed ID: 6683518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous azlocillin kinetics in patients on long-term hemodialysis.
    Aletta JM; Francke EF; Neu HC
    Clin Pharmacol Ther; 1980 Apr; 27(4):563-6. PubMed ID: 7357815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of azlocillin in healthy subjects.
    Leroy A; Humbert G; Fillastre JP
    Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of azlocillin in impaired renal function and haemodialysis (author's transl)].
    Schurig R; Kampf D; Becker H; Förster D
    Arzneimittelforschung; 1979; 29(12a):1944-8. PubMed ID: 543896
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of mezlocillin during haemodialysis.
    Thorsteinsson SB; Steingrimsson O; Asmundsson P; Bergan T
    Scand J Infect Dis Suppl; 1981; 29():59-63. PubMed ID: 6458883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Godin M; Fillastre JP
    Antimicrob Agents Chemother; 1980 Mar; 17(3):344-9. PubMed ID: 7425600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmakokinetic and clinical studies with azlocillin in paediatrics (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Richter I; Thiemann HH
    Klin Padiatr; 1980 Sep; 192(5):419-29. PubMed ID: 7192337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical results with azlocillin (author's transl)].
    Schacht P; Tettenborn D; Hullmann R; Bruck H
    Arzneimittelforschung; 1979; 29(12a):1981-5. PubMed ID: 396929
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of azlocillin in the treatment of Pseudomonas urinary infections].
    Canton P
    Presse Med; 1984 Mar; 13(13):830-3. PubMed ID: 6231606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of acylureidopenicillin pharmacokinetics.
    Bergan T
    Scand J Infect Dis Suppl; 1981; 29():33-48. PubMed ID: 7031864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of azlocillin and ticarcillin in the treatment of urinary tract infection.
    Reed WP; Palmer DL
    J Antimicrob Chemother; 1983 May; 11 Suppl B():189-93. PubMed ID: 6619028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of underdosing of ampicillin/sulbactam in patients with acute kidney injury undergoing extended daily dialysis--a single case.
    Kielstein JT; Lorenzen J; Kaever V; Burhenne H; Broll M; Hafer C; Burkhardt O
    Nephrol Dial Transplant; 2009 Jul; 24(7):2283-5. PubMed ID: 19225017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of azlocillin and ticarcillin in the treatment of complicated urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1983 May; 11 Suppl B():183-8. PubMed ID: 6352601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.